Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2000-10-17
pubmed:abstractText
Despite published reports regarding the association of elevated circulating CD44 and CD54 levels with unfavorable outcome in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL), little is known about therapy-related changes in either adhesion molecule. In an attempt to evaluate the effect of interferon-alpha (IFNalpha), the authors measured serum CD44 (sCD44) and sCD54 in 22 low grade NHL and 14 CLL patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1474-81
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11013360-Adolescent, pubmed-meshheading:11013360-Adult, pubmed-meshheading:11013360-Aged, pubmed-meshheading:11013360-Antigens, CD44, pubmed-meshheading:11013360-Antineoplastic Agents, pubmed-meshheading:11013360-Female, pubmed-meshheading:11013360-Humans, pubmed-meshheading:11013360-Immunohistochemistry, pubmed-meshheading:11013360-Intercellular Adhesion Molecule-1, pubmed-meshheading:11013360-Interferon-alpha, pubmed-meshheading:11013360-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:11013360-Lymphoma, Non-Hodgkin, pubmed-meshheading:11013360-Male, pubmed-meshheading:11013360-Middle Aged, pubmed-meshheading:11013360-Predictive Value of Tests, pubmed-meshheading:11013360-Recombinant Proteins, pubmed-meshheading:11013360-Sensitivity and Specificity, pubmed-meshheading:11013360-Tumor Markers, Biological
pubmed:year
2000
pubmed:articleTitle
Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment.
pubmed:affiliation
Ankara University, School of Medicine, Ibni Sina Hospital, Department of Hematology, Sihhiye, Ankara, Turkey. mbeksac@ato.org.tr
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't